Your session is about to expire
← Back to Search
iPeer2Peer Mentorship for Juvenile Idiopathic Arthritis (iPeer2Peer Trial)
iPeer2Peer Trial Summary
This trial will compare the effects of the iPeer2Peer program (teens with arthritis matched to an older mentor) to a control group (teens with arthritis with no mentor) on measures of disease activity, quality of life, and psychological outcomes.
- Juvenile Idiopathic Arthritis
iPeer2Peer Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iPeer2Peer Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are already involved in other programs that provide support or help you manage your condition.You have significant medical or mental health conditions that could affect how you feel about your quality of life.You have significant problems with your memory or thinking abilities.
- Group 1: iPeer2Peer Mentorship
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many persons are participating in this research project?
"To complete this medical trial, 262 eligible patients will be needed. Participants have the choice of being enrolled at either BC Children's Hospital in Vancouver or The IWK Health Centre in Halifax."
Who is qualified to participate in this clinical experiment?
"This medical investigation is looking for 262 participants between the ages of 12 and 18, who have been diagnosed with juvenile arthritis."
Is eligibility for this research initiative limited to individuals beyond the age of 45?
"The minimum age of admittance to this trial is 12, while the maximum allowable enrolment age is 18."
What is the current geographic distribution of this trial?
"This clinical investigation is recruiting participants from BC Children's Hospital in Vancouver, IWK Health Centre in Halifax and the London Health Sciences' Children's Hospital of Ontario. An additional 6 sites are also taking part."
Is enrollment in this trial currently accessible?
"The protocol, which was initially posted on March 28th 2017 and last edited October 24th 2022 is currently recruiting participants."
Share this study with friends
Copy Link
Messenger